Teleflex Acquires Palette Life Sciences

October 10, 2023

Teleflex Incorporated completed its acquisition of Palette Life Sciences AB for $600 million in upfront cash plus up to $50 million in potential milestone payments. The deal adds Palette’s NASHA-based products — including the Barrigel rectal spacer, Deflux and Solesta — to Teleflex’s interventional urology portfolio; Palette’s standalone net revenue was expected to be about $56 million for 2023.

Buyers
Teleflex Incorporated
Targets
Palette Life Sciences AB
Industry
Medical Devices
Location
Sweden
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.